Actinium Pharmaceuticals Inc. sell Lokrim
Start price
17.08.24
/
20%
€1.63
Target price
17.08.25
-
Performance (%)
-13.83%
End price
18.08.25
€1.40
Summary
This prediction ended on 18.08.25 with a price of €1.40. The prediction for Actinium Pharmaceuticals Inc. closed with a convincing performance of -13.83%. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Actinium Pharmaceuticals Inc. | 4.739% | 4.739% | 10.708% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
According to Lokrim what are the pros and cons of Actinium Pharmaceuticals Inc. for the foreseeable future?
Pros
Cons
Revenue decline/stagnation expected
Risky Investment
Comments by Lokrim for this prediction
In the thread Actinium Pharmaceuticals Inc. diskutieren
Sell Actinium Pharmaceuticals Inc.
In the thread Trading Actinium Pharmaceuticals Inc.
Die von Lokrim gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Lokrim for Actinium Pharmaceuticals Inc.
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.37
09.12.23
09.12.23
-
09.12.24
09.12.24
-
11.12.23
11.12.23
Could be very worthwhile Investment >20% year
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.12
13.11.23
13.11.23
-
13.11.24
13.11.24
28.64%
09.12.23
09.12.23
Could be very worthwhile Investment >20% year